Keyphrases
Therapeutic Potential
100%
Liver Fibrosis
100%
Carbon Tetrachloride
100%
Stem Cells from Human Exfoliated Deciduous Teeth
100%
Capacity Potential
100%
Human Leukocyte Antigen
83%
Liver
66%
Transplantation
50%
Human Albumin
50%
Hepatocyte-specific
50%
Liver Disease
33%
Specific Genes
33%
Liver Regeneration
33%
Cell Source
33%
Human Hepatocytes
33%
Liver Dysfunction
33%
Hepatocyte Paraffin 1
33%
Hepatic Dysfunction
33%
CCl4-induced Liver Fibrosis
33%
Liver Fibrosis Stage
33%
Therapeutic Effect
16%
Urea
16%
Stem Cells
16%
Liver Transplantation
16%
Spleen
16%
Therapeutic Efficacy
16%
Transferrin
16%
Genomic DNA (gDNA)
16%
Treatment Effect
16%
Liver Tissue
16%
Human-to-human
16%
Albumin
16%
Human Blood
16%
Anti-inflammatory Effect
16%
Blood Urea Nitrogen
16%
Liver Cells
16%
Hepatocytes
16%
Antifibrotic
16%
Cytochrome P450 1A1 (CYP1A1)
16%
Homing Effect
16%
Cell Fusion
16%
Biological Assay
16%
Alternative Therapy
16%
Mature Cell
16%
Mouse Liver
16%
Transthyretin
16%
Hepatocyte Differentiation
16%
Donor Cells
16%
Donor Organs
16%
Tyrosine Aminotransferase
16%
Gene Assay
16%
Specific Antigen
16%
Flow Cytometric
16%
Fusogenicity
16%
Uridine Diphosphate Glucuronosyltransferase
16%
Medicine and Dentistry
Stem Cell
100%
Deciduous Teeth
100%
Liver Fibrosis
100%
Hepatocyte
100%
Carbon Tetrachloride
85%
Human Leukocyte Antigen
71%
Liver Dysfunction
57%
Human Albumin
42%
Liver Disease
28%
Liver Regeneration
28%
Carbon Tetrachloride-Induced Liver Fibrosis
28%
Combination Therapy
14%
In Vitro
14%
Transferrin
14%
Transthyretin
14%
Liver Transplantation
14%
Treatment Effect
14%
Genomic DNA
14%
Therapy Effect
14%
Antigen Specificity
14%
Cell Fusion
14%
Glucuronosyltransferase
14%
Bioassay
14%
Cytochrome P450 1A1
14%
Liver Tissue
14%
Fumarylacetoacetase
14%
Tyrosine Aminotransferase
14%
Antiinflammatory Activity
14%
Blood Urea Nitrogen
14%
Liver Cell
14%
Organ Donor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Carbon Tetrachloride
100%
Liver Fibrosis
100%
Leukocyte Antigen
83%
Liver Dysfunction
66%
Human Albumin
50%
Liver Disease
33%
Mouse Model
33%
Carbon Tetrachloride-Induced Liver Fibrosis
33%
Genomic DNA
16%
Combination Therapy
16%
Therapeutic Effect
16%
Transferrin
16%
Transthyretin
16%
Antiinflammatory Activity
16%
Ureaplasma
16%
Fumarylacetoacetase
16%
Tyrosine Aminotransferase
16%
Glucuronosyltransferase
16%
Cytochrome P450 1A1
16%
Uridine
16%
Bioassay
16%